This study looks at how well two medicines, macupatide and eloralintide, help adults with obesity or overweight and type 2 diabetes lose weight. Type 2 diabetes is when your body can’t use insulin properly, and insulin is a hormone that helps control blood sugar. The study lasts about 48 weeks (almost a year).
Eligibility: Participants should have type 2 diabetes and meet certain conditions. For example, they should have a stable weight and be taking diabetes medicine or managing with diet and exercise. They should not have other types of diabetes or recent heart problems.
- Study lasts about 48 weeks.
- Participants must be adults with type 2 diabetes and stable weight.
- No recent use of certain diabetes medicines or heart problems.